IMRN logo
IMRN NASDAQ AU

Immuron Limited - American Depositary Shares

Healthcare · Biotechnology Website · IPO Apr 1999
$0.80
▼ $-0.01 (-0.74%)
Vol 18K
6
Quality Score
fail
Mkt Cap
$11.8M
ROE
-56.7%
Margin
-71.6%
D/E
0.00
Beta
1.40
52W
$0–$0

Price Chart

Similar Stocks

NEUP
Neuphoria Therapeutics Inc
$20.9M

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -56.7% -63.8% -57.2% -56.7% -56.7% -56.7%
P/E (TTM) — — — — — —
Net Margin -82.8% -112.4% -72.1% -71.6% -71.6% -71.6%
Gross Margin 64.0% 67.5% 65.4% 65.4% 65.4% 65.4%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.09 6.80 5.07 5.09 5.09 5.09

Key Ratios

ROA (TTM)
-46.8%
P/S (TTM)
1.61
P/B
1.8
EPS (TTM)
$-0.02
Rev Growth 3Y
+112.0%
52W High
$0.10
52W Low
$0.03
$0.03 52-Week Range $0.10

How does IMRN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

IMRN AAPG ABEO ABOS ABP

IMRN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.6
▼ 87% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.8
▼ 29% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

IMRN profitability vs Biotechnology peers

ROE
-56.7%
▲ 16% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-71.6%
▲ 75% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
65.4%
▼ 17% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-46.8%
▼ 0% below peers (-46.7%)
vs Peers
vs Industry
In line

IMRN financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.1
▲ 15% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.4
▲ 44% above peers (1.0)
vs Peers
vs Industry
More volatile

IMRN fundamentals radar

IMRN Peer median Industry

IMRN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IMRN vs peers: key metrics

Latest News

No related news yet